Skip to main content

REVIEW article

Front. Immunol., 20 August 2021
Sec. Cancer Immunity and Immunotherapy
Volume 12 - 2021 | https://doi.org/10.3389/fimmu.2021.699746

RETRACTED: Harnessing TRAIL-Induced Apoptosis Pathway for Cancer Immunotherapy and Associated Challenges

Retracted

A retraction of this article was approved in:

  1. Retraction: Harnessing TRAIL-induced apoptosis pathway for cancer immunotherapy and associated challenges

    1. Read retraction
Ehsan RazeghianEhsan Razeghian1Wanich SuksatanWanich Suksatan2Heshu Sulaiman Rahman,Heshu Sulaiman Rahman3,4Dmitry O. Bokov,Dmitry O. Bokov5,6Walid Kamal Abdelbasset,Walid Kamal Abdelbasset7,8Ali HassanzadehAli Hassanzadeh9Faroogh MarofiFaroogh Marofi10Mahboubeh YazdanifarMahboubeh Yazdanifar11Mostafa Jarahian*Mostafa Jarahian12*
  • 1Human Genetics Division, Medical Biotechnology Department, National Institute of Genetics Engineering and Biotechnology (NIGEB), Tehran, Iran
  • 2Faculty of Nursing, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok, Thailand
  • 3Department of Physiology, College of Medicine, University of Suleimanyah, Suleimanyah, Iraq
  • 4Department of Medical Laboratory Sciences, Komar University of Science and Technology, Sulaimaniyah, Iraq
  • 5Institute of Pharmacy, Sechenov First Moscow State Medical University, Moscow, Russia
  • 6Laboratory of Food Chemistry, Federal Research Center of Nutrition, Biotechnology and Food Safety, Moscow, Russia
  • 7Department of Health and Rehabilitation Sciences, College of Applied Medical Sciences, Prince Sattam bin Abdulaziz University, Al Kharj, Saudi Arabia
  • 8Department of Physical Therapy, Kasr Al-Aini Hospital, Cairo University, Giza, Egypt
  • 9Department of Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
  • 10Immunology Research Center (IRC), Tabriz University of Medical Sciences, Tabriz, Iran
  • 11Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA, United States
  • 12Toxicology and Chemotherapy Unit (G401), German Cancer Research Center, Heidelberg, Germany

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Razeghian E, Suksatan W, Sulaiman Rahman H, Bokov DO, Abdelbasset WK, Hassanzadeh A, Marofi F, Yazdanifar M and Jarahian M (2021) Harnessing TRAIL-Induced Apoptosis Pathway for Cancer Immunotherapy and Associated Challenges. Front. Immunol. 12:699746. doi: 10.3389/fimmu.2021.699746

Received: 24 April 2021; Accepted: 05 August 2021;
Published: 20 August 2021; Retracted: 04 September 2023.

Edited by:

Fabrizio Mattei, National Institute of Health (ISS), Italy

Reviewed by:

Michael Kalafatis, Cleveland University, United States
Thomas Griffith, University of Minnesota Twin Cities, United States

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.